Clinical trial for Substance Use
Official title Mobile Technology to Reduce Teen Substance Misuse
ClinicalTrials.gov ID: NCT05897164
What this study is testing
- What it's testing
- The study tests a new version of the WisePath for Teens app to see if it can help parents use evidence‑based techniques to reduce teens’ substance use and related mental health issues.
- Who it's for
- Teenagers who use substances and their parents or guardians.
- What's involved
- Participants will use the app on their phones, receive guidance and support, and may have brief check‑ins with study staff.
- Time commitment
- The study lasts several months, with regular app use and occasional study visits or calls to track progress.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 and older
You may be able to join if
- Resides in United States
- 13-17 years of age
- Fluent in English
- Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan that they use on a daily basis
- Currently residing in the same household with the linked caregiver/legal guardian participant at least five days a week
You likely can't join if
- Participated in previous iKinnect or WisePath for Teens research in the past 2 years
- Currently involved with the child protective service system due to a concern about child maltreatment (i.e., abuse or neglect).
See the full eligibility criteria
- Resides in United States
- 13-17 years of age
- Fluent in English
- Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan that they use on a daily basis
- Currently residing in the same household with the linked caregiver/legal guardian participant at least five days a week
- Meets criteria for mild-moderate or severe SA (for any drug or alcohol) on the Screening to Brief Intervention (S2BI), indicated by answering that they have used any substance at least once per month within the past 90...
- Resides in United States
- 18 years or older
- Fluent in English
- Owns and is the primary user of an Android or iPhone-based smartphone with a data plan that they use on a daily basis
- Able and willing to receive and send several (1-3 times/week) text messages from study staff during study participation
- Is the primary caregiver of a youth aged 13-17 years who lives in the caregiver's home at least five days a week
- uses alcohol, marijuana, and/or another substance, AND
- expresses that they are concerned (a score of 3 or higher) about that use on a 5-pt Likert scale (3 = concerned, 4 = very concerned, 5 = extremely concerned). OR
- The target youth participated in counseling or another form of treatment (e.g., medication assisted treatment) because of a concern about alcohol, marijuana, or other substance use.
- Participated in previous iKinnect or WisePath for Teens research in the past 2 years
- Currently involved with the child protective service system due to a concern about child maltreatment (i.e., abuse or neglect).
The study team makes the final eligibility decision.
Where it is enrolling
- Baltimore, Maryland, United States
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Baltimore, Maryland, United States; Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.